The independent source for health policy research, polling, and news.
21-40 of 559 results
The recent outbreak of a foodborne parasite sickened thousands and hospitalized hundreds across the U.S. before federal investigators identified the suspected source. Food safety experts say cuts to the public health system hobbled the response — and that the next outbreak could be much worse.
Bill Cassidy of Louisiana chairs the Senate’s health committee. In an interview with KFF Health News’ Julie Rovner, he discusses the drug supply, his proposal to defray out-of-pocket costs, and his controversial vote to confirm Robert F. Kennedy Jr. as health secretary.
Federal officials charged two virologists they stopped en route from an African disease outbreak with violating import rules. But scientists tell KFF Health News the inactivated samples they carried posed no threat to the public, and they characterize the arrests as part of a government harassment campaign.
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, Erica Schwartz, expressed support for vaccines, including covid shots, in her confirmation hearing. That contrasts with the stance of health secretary Robert F. Kennedy Jr.
From screwworm to flesh-eating bacteria, mounting public health risks are emerging in the wake of deep cuts to federal health agencies and programs.
Massachusetts passed laws and joined lawsuits to protect access to gender-affirming care for minors. But faced with the Trump administration’s threats, some hospitals voluntarily stopped care. Families are outraged.
Four years after the Volunteer State enacted the nation’s first law allowing drugstores to sell ivermectin without patient-specific prescriptions, dozens of pharmacies dispense the drug in highly concentrated pills — many with the help of one anti-vaccine physician.
Mehmet Oz, head of the Centers for Medicare & Medicaid Services, framed the $50 billion Rural Health Transformation Program as “bold, creative plans” led by states. But as states have started to roll out their plans, federal officials control where and how the money is spent.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
The Trump administration has pursued an extensive pro-tobacco agenda as the president and his political movement have been buoyed by a flood of tobacco industry money, federal records show.
The FDA has approved the sunscreen chemical bemotrizinol, a UV light filter that has been available in Europe, Asia, and Australia for more than 20 years. Health advocates and skin care industry groups alike are hopeful it can restore faith in sunscreen.
Health secretary Robert F. Kennedy Jr.’s new autism panel is championing a controversial communication method popular among parents of severely autistic people. Critics warn of abuse — and fake “telepathy.”
To collect and scrutinize millions of Americans’ health data, U.S. health secretary Robert F. Kennedy Jr. aims to work with state organizations that help health systems share medical records. In Nebraska, millions in federal dollars has flowed into one nonprofit cooperating with Kennedy’s project.
Health experts and advocates for low-income people say federal rules implementing President Donald Trump’s new Medicaid work requirements upend months of work by state governments to prepare the computer systems that determine who’s eligible for benefits.
Doctors, lawmakers, and other advocates are joining forces to promote recommended childhood vaccines.
The work of Peter Aaby and Christine Stabell Benn has long been controversial. Until Robert F. Kennedy Jr. became the U.S. health policy chief, most vaccine scientists tended to ignore it. That has changed.
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
© 2026 KFF